IP Library Granted Patent US 8,852,232
Granted Patent B2
US 8,852,232 · App. 12/850,035 · Granted Oct 7, 2014

Self-retaining sutures having effective holding strength and tensile strength

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,852,232
App. No.
12/850,035
Granted
Oct 7, 2014
Kind
B2
Abstract

A barbed suture with a first end and a second end and a body with a plurality of barbs extending from the body. Each barb causes the suture to resist movement in an opposite direction from which the barb faces. Projections extend from said suture. The projections can also engage tissue. The barbs cover the projections when the first end of the suture is moved in tissue and exposes the projections in order to engage tissue when the suture is moved in the direction of the second end through tissue.

Claims (20)

1. A wound-closure device comprising: a strand of monofilament suture, having a first end, a second end, a longitudinal axis, a surface and a diameter (D), having a minimum knot pull strength requirement (S); a plurality of angled cuts present in the surface of the strand and spaced along the strand; each angled cut giving rise to a tissue-retaining element; the plurality of angled cuts defining a plurality of tissue-retaining elements spaced along the strand; the plurality of tissue-retaining elements being adapted to permit movement of the strand through tissue in a direction of the first end and resist movement of the strand through tissue in an opposite direction; each tissue-retaining element having a tip separated from the strand and a base connected to the strand, and further having an underside which attaches the tissue-retaining element to the strand along a concave arcuate line; each tissue-retaining element having a length no less than about 0.8 diameters (0.8*D), measured tip-to-base along the longitudinal axis; the tissue-retaining elements being spaced at a distance no larger than two diameters (2*D), measured tip-to-tip along the longitudinal axis; and the wound-closure device having a tensile strength no less than about 80% of the USP minimum knot pull strength requirement (S) for monofilament suture of the diameter (D).

2. The wound-closure device of claim 1 , wherein the plurality of tissue-retaining elements is effective to resist movement of the suture thread in the opposite direction by holding tissue with a straight pull strength no less than about 80% of the USP minimum knot pull strength requirement (S) for monofilament suture of the diameter (D).

3. The wound-closure device of claim 1 , wherein the diameter (D) is less than about 0.5 mm.

4. The wound-closure device of claim 1 , wherein the plurality of tissue-retaining elements includes at least thirty (30) tissue-retaining elements.

5. The wound-closure device of claim 4 , wherein the plurality of tissue-retaining elements includes a first set of at least ten tissue-retaining elements, a second set of at least ten tissue-retaining elements and a third set of at least ten tissue-retaining elements, the first set of at least ten tissue-retaining elements being radially displaced by 120 degrees from the second set of at least ten tissue-retaining elements, the third set of at least ten tissue-retaining elements being radially displaced by 120 degrees from the first set of at least ten tissue-retaining elements and from the second set of at least ten tissue-retaining elements.

6. The wound-closure device of claim 1 , wherein each tissue-retaining element has a length no less than about one diameter (1*D).

7. The wound-closure device of claim 1 , further comprising a second plurality of tissue-retaining elements longitudinally-displaced from the first plurality of tissue-retaining elements and adapted to permit movement of the strand through tissue in a direction of the second end and resist movement of the strand through tissue in an opposite direction.

8. The wound-closure device of claim 1 , wherein each tip is pointed.

9. The wound-closure device of claim 1 , wherein the monofilament suture comprises a copolymer of glycolide and caprolactone.

10. The wound-closure device of claim 1 , wherein the monofilament suture comprises a copolymer of glycolide and trimethylene carbonate.

11. A self-retaining suture comprising: a strand of polymer, having a first end, a second end, a longitudinal axis, a surface and a diameter (D), having a minimum knot pull strength requirement (S); a plurality of angled cuts present in the surface of the strand and spaced along the strand; each angled cut giving rise to a tissue-retaining element; the plurality of angled cuts defining a plurality of tissue-retaining elements spaced along the strand, each tissue-retaining element having an apex separated from the strand and a base connected to the strand, and further having an underside which attaches the tissue-retaining element to the strand along a concave arcuate line; the plurality of tissue-retaining elements being adapted to permit movement of the strand through tissue in a direction of the first end and resist movement of the strand through tissue in an opposite direction; each tissue-retaining element having a length no less than about 0.8 diameters (0.8*D), measured apex-to-base along the longitudinal axis; the tissue-retaining elements being spaced at a distance no larger than two diameters (2*D), measured apex-to-apex along the longitudinal axis; and the wound-closure device having a tensile strength no less than about 80% of the USP minimum knot pull strength requirement (S) for suture of the diameter (D).

12. The self-retaining suture of claim 11 , wherein the plurality of tissue-retaining elements is effective to resist movement of the suture thread in the opposite direction by holding tissue with a straight pull strength no less than about 80% of the USP minimum knot pull strength requirement (S) for suture of the diameter (D).

13. The self-retaining suture of claim 11 , wherein the diameter (D) is less than about 0.5 mm.

14. The self-retaining suture of claim 11 , wherein the plurality of tissue-retaining elements includes more than thirty (30) tissue-retaining elements.

15. The self-retaining suture of claim 11 , wherein the plurality of tissue-retaining elements includes a first set of at least ten tissue-retaining elements, a second set of at least ten tissue-retaining elements and a third set of at least ten tissue-retaining elements, the first set of at least ten tissue-retaining elements being radially displaced by 120 degrees from the second set of at least ten tissue-retaining elements, the third set of at least ten tissue-retaining elements being radially displaced by 120 degrees from the first set of at least ten tissue-retaining elements and from the second set of at least ten tissue-retaining elements.

16. The self-retaining suture of claim 11 , wherein the polymer comprises a copolymer of glycolide and trimethylene carbonate.

17. The self-retaining suture of claim 11 , wherein the polymer comprises a copolymer of glycolide and caprolactone.

18. The self-retaining suture of claim 11 , wherein each apex is pointed.

19. A wound-closure device comprising: a strand of bioabsorbable polymer suture, having a first end, a second end, a longitudinal axis, a surface and a diameter (D), having a minimum knot pull strength requirement (S); a plurality of angled cuts present in the surface of the strand and spaced along the strand; each angled cut giving rise to a tissue-retaining element; the plurality of angled cuts defining a plurality of tissue-retaining elements spaced along the strand, each tissue-retaining element having an apex separated from the strand and a base connected to the strand, and further having an underside which attaches the tissue-retaining element to the strand along a concave arcuate line; the plurality of tissue-retaining elements being adapted to permit movement of the strand through tissue in a direction of the first end and resist movement of the strand through tissue in an opposite direction; each tissue-retaining element having a length no less than about 0.8 diameters (0.8*D), measured apex-to-base along the longitudinal axis; the tissue-retaining elements being spaced at a distance a spacing no larger than two diameters (2*D), measured apex-to-apex along the longitudinal axis; wherein the diameter (D) is less than 1 mm; and the tensile strength is greater than 7 lbs.

20. The wound-closure device of claim 19 , wherein the plurality of tissue-retaining elements includes more than thirty (30) tissue-retaining elements.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 12, 2013
From: WELLS FARGO CAPITAL FINANCE, LLC
To: ANGIOTECH PHARMACEUTICALS, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; ANGIOTECH INTERNATIONAL HOLDINGS CORP.
Reel/Frame 030211/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2012
From: ANGIOTECH PHARMACEUTICALS, INC.; QUILL MEDICAL, INC.
To: ETHICON, INC.; ETHICON, LLC
Reel/Frame 029294/0443 →
PARTIAL RELEASE OF SECURITY INTERESTS - PATENTS (US) Recorded May 16, 2012
From: WELLS FARGO CAPITAL FINANCE, LLC
To: QUILL MEDICAL, INC.; ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 028216/0499 →
PARTIAL RELEASE OF SECURITY INTERESTS - PATENTS (US) Recorded Apr 20, 2012
From: DEUTSCHE BANK NATIONAL TRUST COMPANY
To: QUILL MEDICAL, INC.; ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 028078/0699 →
PARTIAL RELEASE OF SECURITY INTEREST - PATENTS Recorded Apr 10, 2012
From: WELLS FARGO CAPITAL FINANCE, LLC
To: QUILL MEDICAL, INC.; ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 028022/0861 →
PATENT SECURITY AGREEMENT Recorded May 13, 2011
From: ANGIOTECH PHARMACEUTICALS, INC.; AFMEDICA, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH DELAWARE, INC.; ANGIOTECH FLORIDA HOLDINGS, INC.; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; NEUCOLL INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; 0741693 BRITISH COLUMBIA LTD.; ANGIOTECH INTERNATIONAL HOLDINGS, CORP.
To: WELLS FARGO CAPITAL FINANCE, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 026275/0507 →
PATENT SECURITY AGREEMENT Recorded Aug 19, 2010
From: ANGIOTECH PHARMACEUTICALS, INC.; AFMEDIA, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH CAPITAL, LLC; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; CRIMSON CARDINAL CAPITAL, LLC; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; NEUCOLL, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALITIES CORPORATION; 0741693 B.C. LTD.; 3091796 NOVA SCOTIA COMPANY; ANGIOTECH INTERNATIONAL HOLDINGS, CORP.; ANGIOTECH INVESTMENT PARTNERSHIP
To: WELLS FARGO FOOTHILL, LLC, AS AGENT
Reel/Frame 024861/0219 →